PUBLISHER: The Business Research Company | PRODUCT CODE: 1720922
PUBLISHER: The Business Research Company | PRODUCT CODE: 1720922
Ventral hernia treatment involves medical procedures and interventions to repair hernias occurring in the abdominal wall. Common approaches include robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal techniques. The goal of treatment is to reposition displaced tissues, reinforce the abdominal wall, and prevent recurrence, ultimately relieving pain, restoring normal function, and reducing complications such as bowel obstruction or strangulation.
The primary types of ventral hernia treatment include epigastric (stomach area) hernia, umbilical (belly button) hernia, and incisional hernia. An epigastric hernia occurs when fatty tissue pushes through a weakened area in the upper abdominal wall between the sternum and the belly button. Diagnosis is performed using ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI). Treatment options include various surgical procedures such as open hernia surgery, laparoscopic surgery, and robotic hernia surgery. These treatments are utilized in hospitals, ambulatory surgical centers, and clinics.
The ventral hernia treatment market research report is one of a series of new reports from The Business Research Company that provides ventral hernia treatment market statistics, including ventral hernia treatment industry global market size, regional shares, competitors with a ventral hernia treatment market share, detailed ventral hernia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ventral hernia treatment industry. This ventral hernia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ventral hernia treatment market size has grown strongly in recent years. It will grow from $4.87 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the rising prevalence of obesity, increased awareness of ventral hernias, a growing aging population, higher disposable income, and the increasing demand for minimally invasive surgical procedures.
The ventral hernia treatment market size is expected to see strong growth in the next few years. It will grow to $6.90 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the rising demand for outpatient procedures, increased healthcare spending, growing government initiatives, a higher demand for hernia repair surgeries, and increased investment in research and development. Key trends during this period include advancements in hernia repair devices, the use of bioabsorbable materials, strategic collaborations, the development of robotic-assisted surgery devices, and the adoption of remote monitoring technologies.
The rising prevalence of obesity is significantly contributing to the growth of the ventral hernia treatment market. Obesity, a condition characterized by excessive body fat, increases the risk of ventral hernias due to the added strain on the abdominal wall. Factors such as poor diet, sedentary lifestyle, genetic predisposition, and lack of physical activity have led to an increase in obesity rates worldwide. Ventral hernia treatment plays a crucial role in managing complications associated with obesity by alleviating abdominal strain, reducing hernia recurrence risk, and improving overall abdominal strength. According to the World Health Organization (WHO), as of March 2024, one in eight people globally were struggling with obesity, including 2.5 billion overweight adults, with 890 million classified as obese. Additionally, 37 million children under the age of five were reported to be overweight. This growing obesity epidemic is expected to drive demand for ventral hernia treatments.
Technological advancements in hernia treatment are further propelling market growth. Companies are developing innovative solutions, such as laparoscopic and open hernia mesh fixation devices, to improve surgical outcomes and patient recovery. Laparoscopic and open hernia mesh fixation devices secure mesh during hernia repair surgeries, either through minimally invasive (laparoscopic) or traditional open approaches. In March 2024, TELA Bio Inc. introduced LIQUIFIX FIX8 and LIQUIFIX Precision in the U.S. The LIQUIFIX FIX8 device is designed for minimally invasive hernia repairs, while LIQUIFIX Precision is optimized for open femoral and inguinal hernia procedures. These FDA-approved devices utilize liquid anchors to secure mesh without penetrating tissue, thereby reducing trauma and minimizing complications. Given that over 1.2 million hernia procedures are performed annually in the U.S., such advancements offer safer and more precise treatment options.
In August 2023, Steris plc acquired the surgical instrumentation assets of Becton, Dickinson, and Company to strengthen its healthcare portfolio. This acquisition expands Steris plc's offerings in the surgical instrumentation market, allowing it to provide advanced tools and technologies to hospitals and surgical centers. By integrating these assets, Steris enhances its ability to deliver comprehensive solutions in the medical device industry while supporting growth in the ventral hernia treatment market.
Major players in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Molnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in ventral hernia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ventral hernia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ventral hernia treatment market consists of revenues earned by entities by providing services such as surgical consultations, hernia repair surgeries, post-operative care, diagnostic imaging and others. The market value includes the value of related goods sold by the service provider or included within the service offering. The ventral hernia treatment market also includes sales of fixation devices, surgical instruments, wound care products, surgical sutures and staplers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ventral Hernia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ventral hernia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ventral hernia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ventral hernia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.